Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
EBAG9
Introduction
Receptor-binding cancer antigen expressed on SiSo cells is a protein that in humans is encoded by the EBAG9 gene.
This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5′-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Two transcript variants differing in the 5′ UTR, but encoding the same protein, have been identified for this gene.[1]
References
References
Further reading
Further reading
- Bonaldo MF, Lennon G, Soares MB (1997). “Normalization and subtraction: two approaches to facilitate gene discovery”. Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
- Watanabe T, Inoue S, Hiroi H, et al. (1998). “Isolation of Estrogen-Responsive Genes with a CpG Island Library”. Mol. Cell. Biol. 18 (1): 442–9. doi:10.1128/mcb.18.1.442. PMC 121513. PMID 9418891.
- Nakashima M, Sonoda K, Watanabe T (1999). “Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1”. Nat. Med. 5 (8): 938–42. doi:10.1038/11383. PMID 10426319.
- Ikeda K, Sato M, Tsutsumi O, et al. (2000). “Promoter analysis and chromosomal mapping of human EBAG9 gene”. Biochem. Biophys. Res. Commun. 273 (2): 654–60. doi:10.1006/bbrc.2000.2920. PMID 10873660.
- Ohshima K, Nakashima M, Sonoda K, et al. (2001). “Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege”. Clin. Exp. Immunol. 123 (3): 481–6. doi:10.1046/j.1365-2249.2001.01461.x. PMC 1906005. PMID 11298137.
- Matsushima T, Nakashima M, Oshima K, et al. (2001). “Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells”. Blood. 98 (2): 313–21. doi:10.1182/blood.V98.2.313. PMID 11435298.
- Tsuneizumi M, Emi M, Nagai H, et al. (2002). “Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers”. Clin. Cancer Res. 7 (11): 3526–32. PMID 11705872.
- Umeoka K, Sanno N, Oyama K, et al. (2002). “Immunohistochemical analysis of RCAS1 in human pituitary adenomas”. Mod. Pathol. 14 (12): 1232–6. doi:10.1038/modpathol.3880467. PMID 11743045.
- Hiraoka K, Hida Y, Miyamoto M, et al. (2002). “High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker”. Int. J. Cancer. 99 (3): 418–23. doi:10.1002/ijc.10381. PMID 11992411.
- Rousseau J, Têtu B, Caron D, et al. (2002). “RCAS1 is associated with ductal breast cancer progression”. Biochem. Biophys. Res. Commun. 293 (5): 1544–9. doi:10.1016/S0006-291X(02)00401-1. PMID 12054692.
- Oizumi S, Yamazaki K, Nakashima M, et al. (2002). “RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung”. Oncology. 62 (4): 333–9. doi:10.1159/000065065. PMID 12138241.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Engelsberg A, Hermosilla R, Karsten U, et al. (2003). “The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens”. J. Biol. Chem. 278 (25): 22998–3007. doi:10.1074/jbc.M301361200. PMID 12672804.
- Abe Y, Ohshima K, Nakashima M, et al. (2003). “Expression of apoptosis-associated protein RCAS1 in macrophages of histiocytic necrotizing lymphadenitis”. Int. J. Hematol. 77 (4): 359–63. doi:10.1007/BF02982644. PMID 12774924.
- Takahashi S, Urano T, Tsuchiya F, et al. (2003). “EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer”. Int. J. Cancer. 106 (3): 310–5. doi:10.1002/ijc.11205. PMID 12845666.
- Sonoda K, Miyamoto S, Hirakawa T, et al. (2003). “Association between RCAS1 expression and clinical outcome in uterine endometrial cancer”. Br. J. Cancer. 89 (3): 546–51. doi:10.1038/sj.bjc.6601126. PMC 2394364. PMID 12888828.
- Leelawat K, Watanabe T, Nakajima M, et al. (2003). “Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer”. J. Clin. Pathol. 56 (10): 764–8. doi:10.1136/jcp.56.10.764. PMC 1770069. PMID 14514780.
- Ikeguchi M, Ohoro S, Maeda Y, et al. (2004). “Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma”. Oncol. Rep. 10 (6): 1891–4. doi:10.3892/or.10.6.1891. PMID 14534714.
- Ikeguchi M, Hirooka Y, Kaibara N (2004). “Gene and protein expression of RCAS1 in hepatocellular carcinoma”. Anticancer Res. 23 (6D): 4967–71. PMID 14981953.
- Brill LM, Salomon AR, Ficarro SB, et al. (2004). “Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry”. Anal. Chem. 76 (10): 2763–72. doi:10.1021/ac035352d. PMID 15144186.